Embarc

VIDA FLaSH Acquisitions

CIK: 1844969

SPAC Overview

0
Withdrawn
Current Status

Timeline Progress

About

VIDA FLaSH Acquisitions is a blank-check company seeking an initial business combination, with a focus on U.S. healthcare businesses, especially growth-stage medical technologies, diagnostics, digital health and genomics companies.

Investment Focus

Healthcare

Geographic Focus

United States

Embarc dashboard

What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.

  • Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
  • Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
  • The full 8-K lifecycle timeline, each event linked to its filing
  • Price history across the unit, share and warrant tickers
  • Follow it, and see it change on your watchlist
Open in the dashboard

SPAC Team

Sponsors

FLaSH Investments

Leadership

R Scott Huennekens
Chairman of the Board of Directors
Frank Litvack M.D.
Chief Executive Officer, Director
John Blake
Chief Financial Officer
Michal Geva
Director Nominee
Renee Gaeta
Director Nominee
Siddhartha Kadia
Director Nominee
Scot Huennekens
Beneficial owner

Underwriters

Goldman Sachs

Extended Team Information

Founders Frank Litvack and Scott Huennekens bring healthcare and medical-technology operating, executive, investment and board experience. The team also includes CFO John Blake and directors/director nominees with venture-capital, healthcare, finance and life-sciences experience.

Key Information

SIC
6770
SPAC Ticker
N/A

External Resources

SEC Filings
View Detailed Analysis